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1. Introduction 
In the course of our attempts to understand the 
phenomenon of facilitated transplacental transport 
and foetal accumulation of riboflavin in pregnant 
higher animals and humans [ 1,2], we found biochemi- 
cal [3] and immunological [4] evidence for the occur- 
rence of a reproduction-specific, high-affinity ribo- 
flavin carrier protein (RCP) in the pregnant rat serum. 
The rodent vitamin carrier exhibited immunological 
cross-reactivity with purified chicken RCP, which, in 
the avian system is obligatory for adequate deposition 
of the vitamin in the egg yolk for proper development 
of the prospective embryo [5,6]. The functional 
importance of the maternal RCP in foetal develop- 
ment and proper progression of pregnancy in the rat 
was demonstrated by acute foetal wastage and abrupt 
pregnancy termination resulting from immunoneu- 
tralisation of the endogenous RCP with specific and 
potent antiserum (a/s) to either the avian [4] or 
rodent vitamin carrier (unpublished). Here, we show 
that pregnancy termination due to passive immuno- 
neutralisation of RCP is the direct consequence of 
drastic curtailment of the vitamin supply leading to 
steep decrease in flavin content and arrest of growth 
culminating in foetal mortality. 
2. Materials and methods 
[2-14C] Riboflavin (31 mCi/mmol) was obtained 
from the Radiochemical Centre (Amersham, Bucks). 
L-[U-‘4C] Ornithine hydrochloride (250 mCi/mmol) 
and [3H]progesterone (101 Ci/mmol) were products 
of New England Nuclear Corp. (Boston MA). The 
sources of other chemicals and reagents used were the 
same as in [S ,6]. The strain of adult female rats and 
their maintenance were as in [4]. Their estrous cycles 
were monitored by microscopic examination of 
vaginal smears. They were mated during estrous period 
with adult males of proven fertility and the day on 
which sperms were detected in the vaginal smears was 
taken as day 1 of pregnancy. Rabbit a/s to purified 
chicken RCP was raised and characterised as in [ 61 
and could neutralise 300 ,ug of the antigen/ml at 
equivalence point. Both this a/s and the non-immu- 
nised rabbit serum (used as control) were incubated 
for 30 min at 52’C to inactivate the complement, if 
any, before intraperitoneally administering to rats on 
day 11 of pregnancy. For measuring embryonic uptake 
of [ 14C] riboflavin, the pregnant animals were injected 
intraperitoneally the labelled vitamin (1 mCi/animal) 
1 h after antiserum treatment (0.5 ml/animal) and the 
embryos were dissected at specified intervals. For 
quantifying [ 14C] riboflavin uptake the embryos were 
homogenised at 4°C in phosphate-buffered saline 
(0.15 M NaCl in 0.05 M sodium phosphate buffer 
(pH 7.2)) and an aliquot of the clarified homogenate 
(spun at 1000 X g, 10 min at 4’C) was digested with 
hyamine hydroxide and counted for radioactivity by 
liquid scintillation spectrometry [7]. The total flavin 
content in embryonic extracts was quantified fluori- 
metrically after deproteinisation and neutralisation to 
pH 7.2 [8]. Progesterone levels in the maternal sera 
were estimated by the specific radioimmunoassay for 
the steroid [9]. Ornithine decarboxylase activity 
(ODC) in embryonic extracts was quantified [lo] by 
measuring 14C01 liberated from [U-‘4C]ornithine. 
Protein was estimated as in [ 1 I]. 
3. Results and discussion 
The time course of foetal uptake of [‘4C]riboflavin 
administered to the rats on day 11 of pregnancy and 
corresponding profiles of fresh weight and ODC activ- 
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Fig.1. The effect of administration of chicken RCP a/s to pregnant rats on: (A) [ “Clriboflavin uptake by embryo; (B) embryonic 
weight; (C) embryonic ODC activity. The ODC assay reaction mixture (1.0 ml) consisted of 100 pmol Tris-HCI buffer @H 7.2), 
50 nmol pyridoxal phosphate, 2 rmol dithioreitol50 I.rg catalase, 1 X 10” cpm of L-[U-‘4C]omithine and -200 ng protein from 
clarified supematant of embryo homogenate. The incubation was carried out at 37°C for 1 h. Control (0); a/s-treated (0). Vertical 
bars represent SD (n = 5). 
ity of the foeto-placental unit over 24 h are depicted 
in fig.1. It is clear that in non-immunised control ani- 
mals, steep linear increase with time of the labelled 
vitamin influx (fig.1 A) was paralleled by a similar 
gain in fresh weight (fig.1 B) and a large and sustained 
enhancement in ODC activity (fig. 1 C). The choice of 
ODC as an additional index of growth is based on 
recent observation that this first and rate-limiting 
enzyme of polyamine biosynthetic pathway in mam- 
mals [ 121, progressively increases in the developing 
rodent embryo registering peak activity on day 12 of 
gestation (remaining elevated thereafter) and that its 
irreversible inhibition by D,L-difluoro-ornithine 
markedly suppresses foetal growth leading to resorp- 
tion [ 131. In sharp contrast to this pattern, in a/s 
treated animals, there was pronounced curtailment of 
embryonic uptake of [ 14C] riboflavin which started 
manifesting as early as 3 h after a/s dosing and 
accounted for -95% inhibition in vitamin influx at 
20 h (fig. 1 A). This was closely followed by marked 
suppression of ODC activity (perceptible at 6-8 h) 
and cessation of growth in terms of fresh weight soon 
thereafter. Thus, it is evident that foetal wastage and 
consequent pregnancy termination following treat- 
ment with RCP a/s [4] are not non-specific but are 
unequivocally due to interference with the vital func- 
tions of maternal RCP as an obligatory vitamin carrier, 
indispensable to embryonic proliferation. In view of 
the temporal relationship among suppressed vitamin 
uptake and the 2 growth parameters, it would appear 
that deranged foetal development is the consequence 
of early acute blockade of vitamin delivery to the 
developing embryo. 
To probe further into the intraembryonic events 
culminating in foetal wastage, in the a/s-treated ani- 
mals, gross changes in the profiles of foetal total flavin 
contents were examined. Fig2A shows that in con- 
trol animals, rapid embryonic growth at this stage of 
pregnancy was attended by a rather slow and mar- 
ginal enhancement (25%) in total flavin content, 
which, however, was not commensurate with corre- 
sponding growth increase (85%); in fact, on unit fresh 
weight basis, foetal flavin content registered an initial 
slow yet significant decrease reaching a plateau level 
(130 pg/mg tissue) at 10 h. Since rapid foetal growth 
was still maintained thereafter, it is conceivable that 
282 
Volume 135, number 2 FEBS LETTERS December 198 1 
I I I I 
6 12 18 24 
-0.20 
9 
(1: 
-0.16 f 
E" 
-0.12 = 
B 
3 
-0.08 p 
ii! 
I I I I I 
6 12 18 24 
TIME (h) AFTER ANTISERUM TREATMENT 
Fig.2. InfIuence of administration ofchicken RCP a/s to pregnant rats on total fIavin content of the embryonic tissue. Total fIavin 
content of deproteinised clarified embryonic homogenates was estimated fluorimetricaIIy by measuring fluorescence (reducible by 
sodium hydrosulpbite) mitted at 530 nm upon excitation at 470 nm [ 81. Control (0); a/s-treated (0). Vertical bars represent SD 
(n = 5). 
this level of the vitamin represents the minimum 
threshold value required to sustain continued tissue 
proliferation. The reasons for these rather unexpected 
nonparallel increments in flavin contents and fresh 
weight, despite the continuous vitamin supply, during 
normal foetal development are not easily explained at 
present. One distinct possibility that this may be 
related to fast turnover rate of the vitamin (presum- 
ably intrinsic to the embryonic tissue) becomes appar- 
ent when the changing pattern of foetal flavin con- 
tent in a/s-treated animals is examined (fig.2A). Early 
deprivation of vitamin supply to the foetus resulted 
in steep and progressive fall in its flavin content (dis- 
proportionate to growth inhibition) reaching a value 
markedly less than that in control animals at a time 
(6-7 h) when growth retardation was still not dis- 
cernible. On a unit fresh weight basis, foetal flavin 
content was clearly less than the plateau level reached 
in control animals at this period (tig.2B). Thus the 
accelerated depletion of flavin beyond the critical 
threshold concentration as a consequence of stoppage 
of vitamin influx seems to be one of the underlying 
mechanisms of foetal wastage in the a/s-treated ani- 
mals. 
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Fig.3. Effects of passive immunoneutrabsation of RCP on pro- 
gesterone l vels in 11 day pregnant rats. Sera prepared from 
blood drawn by cardiac puncture were deproteinised with 
methanol and steroid fraction was extracted with ether, and 
the progesterone levels were measured by radioimmunoassay 
[ 91. Control (e); a/s-treated (0). Vertical bars represent SD 
(n = 5). 
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Further evidence that these early events lead to 
foetal degeneration and hence to pregnancy termina- 
tion was provided by the contrasting pattern of 
maternal progesterone l vels in the a/s-treated animals 
vis-a-vis n non-immunised animals (controls) (fig.3). 
Unlike in the controls, characterised byslow but 
steadily increasing levels of circulatory progesterone 
[ 141, in a/s-treated animals, the hormonal concentra- 
tions in the maternal serum, precipitously fell from 
10 h, signalling foetal distress and consequent shutting 
off of the luteotropic stimulus from the foeto-pla- 
cental unit and hence leutealysis [151. 
Thus, apart from unequivocally confirming our 
observation [4] regarding the paramount functional 
importance of maternal RCP for continuous upply 
of riboflavin to the developing foetus in the mammal, 
these data emphasise that foetal vitamin metabolism 
is in continuous flux and is highly vulnerable to inter- 
ference at the level of transplacental transport itself. 
If is also clear that foetal tissue characterised by fast 
vitamin turnover ate (which probably accounts for a 
very low flavin level in the embryo vis-a-vis normal or 
regenerating rat liver [ 161) has limited capacity to 
survive by neutralising the available intra-embryonic 
vitamin content, Furthermore, the above data also 
demonstrate for the first time that immunological 
interference with the functioning of the carrier pro- 
tein can be exploited for precipitating selective and 
acute embryonic vitamin deficiency thus opening new 
vistas of vitamin research in the foetal tissue. 
Acknowledgement 
The financial assistance from Indian Council of 
Medical Research, New Delhi is gratefully acknowl- 
edged. 
References 
[l] Clarke, H. C. (1977) Int. J. Vitam. Nutr. Res. 47, 
361-363. 
[2] Dancis, J. and Schneider, H. (1975) in: The Placenta 
[31 
141 
151 
[61 
[71 
PI 
and its Maternal Supply Line (Gruenwald, P. ed) 
pp. 98-124, MTP, Lancaster. 
Muniyappa, K. and Adiga, P. R. (1980) Biochem. J. 
187,537-540. 
Muniyappa, K. and Adiga, P. R. (1980) FEBS Lett. 
110,209-212. 
Hammer, C. H., Buss, E. G. and Clagett, C. 0. (1973) 
Poult. Sci. 52,520-530. 
Murty, U. S. and Adiga, P. R. (1977) Ind. J. Biochem. 
Biophys. 14,118-124. 
Muniyappa, K. and Adiga, P. R. (1979) Biochem. J. 
177,887-894. 
Sharada, D. and Bamji, S. (1972) Int. J. Vitam. Nutr. 
Res. 42,43-49. 
[9] Oreczyk, G. P., Hichens, M., Arth, G. and Behrman, 
[lOI 
[Ill 
1121 
1131 
1141 
[I51 
H. R. (1974) in: Methods of Hormone Radioimmuno- 
assay (Jaffe, B. M. and Behrman, H. R. eds) pp. 347-358, 
Academic Press, New York. 
Murty, U. S., Suresh, M. R., Prasad, M. S. K. and Adiga, 
P. R. (1977) Ind. J. Biochem,. Biophys. 14, 319-324. 
Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193,265-275. 
Guha, S. K. and Jamre, J. (1976) Biochim. Biophys. 
Acta 437,244-252. 
Fozard, R. J., Part, M. L., Prakash, N. J., Grove, J., 
Schechter, P. J., Sjoerdsma, A. and Koch-Weser, J. 
(1980) Science 208,505-508. 
Morishige, W. K., Pepe, G. J. and Rothchild, I. (1973) 
Endocrinology 92,1527-1530. 
Mukku, V. and Moudgal, N. R. (1975) Endocrinology 
97,1455-1459. 
[ 161 tireenstein, J. P. (1954) in: Biochemistry of Cancer, 
pp. 327-506, Academic Press, New York. 
284 
